abstract |
the present invention relates to antibodies that bind to alpha-synuclein and fragments thereof capable of binding to alpha-synuclein as a monomer and in fibrils and prevent alpha-synuclein aggregation induced by alpha-synuclein fibrils. the antibodies of the present invention are for use in the treatment of alpha-synucleinopathies, including parkinson's disease. |